These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 17488762

  • 1. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T, Egami K, Tanoue A.
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [Abstract] [Full Text] [Related]

  • 2. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO, Ahmad AA, Ezeokoli CD, Emejuaiwe SO.
    Microbios; 1991 Apr; 67(274):33-6. PubMed ID: 1758308
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antibody response after measles immunization.
    Ariyasriwatana C, Kalayanarooj S, Pattamadilok S.
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [Abstract] [Full Text] [Related]

  • 5. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S, Morishima T, Nishikawa K, Hanada N, Rahman M, Terashima M, Kido S, Ueda S, Takahashi M.
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [Abstract] [Full Text] [Related]

  • 6. Waning immunity and subclinical measles infections in England.
    Glass K, Grenfell BT.
    Vaccine; 2004 Sep 28; 22(29-30):4110-6. PubMed ID: 15364464
    [Abstract] [Full Text] [Related]

  • 7. Immunological response to measles vaccination in poor communities.
    Bhaskaram P, Madhusudan J, Radhrakrishna KV, Raj S.
    Hum Nutr Clin Nutr; 1986 Jul 28; 40(4):295-9. PubMed ID: 3744889
    [Abstract] [Full Text] [Related]

  • 8. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR, Schneider F, Muller CP.
    Vaccine; 2006 Mar 24; 24(14):2594-601. PubMed ID: 16427163
    [Abstract] [Full Text] [Related]

  • 9. Low seroconversion rates to measles vaccine among children in Nigeria.
    Adu FD, Akinwolere OA, Tomori O, Uche LN.
    Bull World Health Organ; 1992 Mar 24; 70(4):457-60. PubMed ID: 1394778
    [Abstract] [Full Text] [Related]

  • 10. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM.
    J Infect Dis; 2004 Jul 01; 190(1):83-90. PubMed ID: 15195246
    [Abstract] [Full Text] [Related]

  • 11. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R, Mahmoodi M, Nategh R, Jelyani KN, Eslami MB, Mohktari-Azad T.
    East Mediterr Health J; 2006 Nov 01; 12(6):775-82. PubMed ID: 17333822
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
    Liu BY, Feng ZX, Xu AQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct 01; 16(5):263-5. PubMed ID: 8706090
    [Abstract] [Full Text] [Related]

  • 14. [Study on the immunization effect of measles vaccine by capture-EIA].
    Fang H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct 01; 13(5):297-9. PubMed ID: 1300252
    [Abstract] [Full Text] [Related]

  • 15. Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria.
    Omilabu SA, Oyefolu AO, Ojo OO, Audu RA.
    Afr J Med Med Sci; 1999 Oct 01; 28(3-4):209-12. PubMed ID: 11205835
    [Abstract] [Full Text] [Related]

  • 16. [A study on measles vaccination rate and its antibody level in children aged 12-24 months in Guangxi, 1989].
    Lin M.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Jun 01; 13(3):138-40. PubMed ID: 1423535
    [Abstract] [Full Text] [Related]

  • 17. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children.
    al-Attar I, Reisman J, Muehlmann M, McIntosh K.
    Pediatr Infect Dis J; 1995 Feb 01; 14(2):149-51. PubMed ID: 7746699
    [No Abstract] [Full Text] [Related]

  • 18. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A, Sukhoo R, Cutts FT, Bennett JV.
    Vaccine; 2007 May 22; 25(21):4170-4. PubMed ID: 17408818
    [Abstract] [Full Text] [Related]

  • 19. [A new combined vaccine against yellow fever and measles in infants aged 6 to 24 months in Mali].
    Soula G, Sylla A, Pichard E, Kodio B, Bentejac MC, Teulières L, Saliou P.
    Bull Soc Pathol Exot; 1991 May 22; 84(5 Pt 5):885-97. PubMed ID: 1819436
    [Abstract] [Full Text] [Related]

  • 20. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine.
    abu Eldan J, Borćić B, Smerdel S.
    Acta Med Croatica; 1991 May 22; 45(4-5):297-304. PubMed ID: 1726513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.